Dickinson Klara

CIK 00013398954 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001339895

Recent Transactions

30 trades

Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−66,500→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−175,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−215,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−328,299→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−78,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−200,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Common Stock
2024-03-22−21,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−100,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−138,312→ 0 total
Award
CymaBay Therapeutics, Inc.
Common Stock
2024-01-24+21,000→ 21,000 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-01-24+78,000→ 78,000 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-01-25+215,000→ 215,000 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2022-01-25+175,000→ 175,000 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2021-01-26+66,500→ 66,500 total
Award
CymaBay Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-15+328,299→ 328,299 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2019-01-29+138,312→ 138,312 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2018-01-24+100,000→ 100,000 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2017-06-28+200,000→ 200,000 total
Award
Anthera Pharmaceuticals Inc
Stock option (right to buy)
2017-05-20+43,750→ 43,750 total
Award
Anthera Pharmaceuticals Inc
Stock option (right to buy)
2016-06-09+105,000→ 105,000 total
Award
Anthera Pharmaceuticals Inc
Stock Option (right to buy)
2016-02-12+8,395→ 8,395 total
Award
Anthera Pharmaceuticals Inc
Stock option (right to buy)
2015-09-17+50,000→ 50,000 total
Award
Anthera Pharmaceuticals Inc
Stock option (right to buy)
2015-09-17+30,000→ 30,000 total
Award
Anthera Pharmaceuticals Inc
Common Stock
2015-06-30$1.49/sh+12,500→ 12,500 total
Award
HYPERION THERAPEUTICS INC
Employee Stock Option (right to buy)
2014-03-11+12,000→ 12,000 total
Award
HYPERION THERAPEUTICS INC
Common Stock
2014-03-11+2,000→ 2,283 total
Award
HYPERION THERAPEUTICS INC
Stock Option (right to buy)
2013-04-15+43,000→ 43,000 total
Conversion
HYPERION THERAPEUTICS INC
Common Stock
2012-07-31+278→ 283 total
Conversion
HYPERION THERAPEUTICS INC
Series C-1 Preferred Stock
2012-07-31−278→ 0 total
Award
COTHERIX INC
Stock Option (Right to Buy)
2006-06-30+30,000→ 30,000 total

Companies

Recent Filings

Address

C/O HYPERION THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 200

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov